157 related articles for article (PubMed ID: 10556945)
1. Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.
Caballero R; Valenzuela C; Longobardo M; Tamargo J; Delpón E
Br J Pharmacol; 1999 Nov; 128(5):1071-81. PubMed ID: 10556945
[TBL] [Abstract][Full Text] [Related]
2. Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels.
Delpón E; Valenzuela C; Gay P; Franqueza L; Snyders DJ; Tamargo J
Cardiovasc Res; 1997 Aug; 35(2):341-50. PubMed ID: 9349397
[TBL] [Abstract][Full Text] [Related]
3. Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
Moreno I; Caballero R; González T; Arias C; Valenzuela C; Iriepa I; Gálvez E; Tamargo J; Delpón E
J Pharmacol Exp Ther; 2003 Feb; 304(2):862-73. PubMed ID: 12538844
[TBL] [Abstract][Full Text] [Related]
4. Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5).
Delpón E; Caballero R; Valenzuela C; Longobardo M; Snyders D; Tamargo J
Cardiovasc Res; 1999 May; 42(2):510-20. PubMed ID: 10533586
[TBL] [Abstract][Full Text] [Related]
5. Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5).
Caballero R; Moreno I; González T; Valenzuela C; Tamargo J; Delpón E
Cardiovasc Res; 2002 Oct; 56(1):104-17. PubMed ID: 12237171
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers.
Valenzuela C; Delpón E; Tamkun MM; Tamargo J; Snyders DJ
Biophys J; 1995 Aug; 69(2):418-27. PubMed ID: 8527655
[TBL] [Abstract][Full Text] [Related]
7. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
Perchenet L; Clément-Chomienne O
J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117
[TBL] [Abstract][Full Text] [Related]
8. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
Perchenet L; Hilfiger L; Mizrahi J; Clément-Chomienne O
J Pharmacol Exp Ther; 2001 Sep; 298(3):1108-19. PubMed ID: 11504808
[TBL] [Abstract][Full Text] [Related]
9. Effects of bupivacaine and a novel local anesthetic, IQB-9302, on human cardiac K+ channels.
González T; Longobardo M; Caballero R; Delpón E; Tamargo J; Valenzuela C
J Pharmacol Exp Ther; 2001 Feb; 296(2):573-83. PubMed ID: 11160646
[TBL] [Abstract][Full Text] [Related]
10. Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5.
Caballero R; Delpón E; Valenzuela C; Longobardo M; Franqueza L; Tamargo J
Br J Pharmacol; 1997 Nov; 122(5):796-8. PubMed ID: 9384491
[TBL] [Abstract][Full Text] [Related]
11. Direct effects of candesartan and eprosartan on human cloned potassium channels involved in cardiac repolarization.
Caballero R; Delpón E; Valenzuela C; Longobardo M; González T; Tamargo J
Mol Pharmacol; 2001 Apr; 59(4):825-36. PubMed ID: 11259627
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of the inhibition of human Kv1.5 potassium currents by external protons and Zn(2+).
Kehl SJ; Eduljee C; Kwan DC; Zhang S; Fedida D
J Physiol; 2002 May; 541(Pt 1):9-24. PubMed ID: 12015417
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of block of a human cloned potassium channel by the enantiomers of a new bradycardic agent: S-16257-2 and S-16260-2.
Delpón E; Valenzuela C; Pérez O; Franqueza L; Gay P; Snyders DJ; Tamargo J
Br J Pharmacol; 1996 Mar; 117(6):1293-301. PubMed ID: 8882628
[TBL] [Abstract][Full Text] [Related]
14. Staurosporine directly blocks Kv1.3 channels expressed in Chinese hamster ovary cells.
Choi JS; Hahn SJ; Rhie DJ; Jo YH; Kim MS
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):256-61. PubMed ID: 10344523
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of antiarrhythmic agent bertosamil on hKv1.5 channels and outward potassium current in human atrial myocytes.
Godreau D; Vranckx R; Hatem SN
J Pharmacol Exp Ther; 2002 Feb; 300(2):612-20. PubMed ID: 11805224
[TBL] [Abstract][Full Text] [Related]
16. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
17. Papaverine blocks hKv1.5 channel current and human atrial ultrarapid delayed rectifier K+ currents.
Choe H; Lee YK; Lee YT; Choe H; Ko SH; Joo CU; Kim MH; Kim GS; Eun JS; Kim JH; Chae SW; Kwak YG
J Pharmacol Exp Ther; 2003 Feb; 304(2):706-12. PubMed ID: 12538825
[TBL] [Abstract][Full Text] [Related]
18. Blockade of HERG and Kv1.5 by ketoconazole.
Dumaine R; Roy ML; Brown AM
J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
[TBL] [Abstract][Full Text] [Related]
19. Interaction of propofol with voltage-gated human Kv1.5 channel through specific amino acids within the pore region.
Kojima A; Ito Y; Ding WG; Kitagawa H; Matsuura H
Eur J Pharmacol; 2015 Oct; 764():622-632. PubMed ID: 26256861
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
